Literature DB >> 22016518

Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

G E Serrano1, N Lelutiu, A Rojas, S Cochi, R Shaw, C D Makinson, D Wang, G A FitzGerald, R Dingledine.   

Abstract

Cyclooxygenase-2 (COX-2), a source of inflammatory mediators and a multifunctional neuronal modulator, is rapidly induced in select populations of cortical neurons after status epilepticus. The consequences of rapid activity-triggered induction of COX-2 in neurons have been the subject of much study and speculation. To address this issue directly, we created a mouse in which COX-2 is conditionally ablated in selected forebrain neurons. Results following pilocarpine-induced status epilepticus indicate that neuronal COX-2 promotes early neuroprotection and then delayed neurodegeneration of CA1 pyramidal neurons, promotes neurodegeneration of nearby somatostatin interneurons in the CA1 stratum oriens and dentate hilus (which themselves do not express COX-2), intensifies a broad inflammatory reaction involving numerous cytokines and other inflammatory mediators in the hippocampus, and is essential for development of a leaky blood-brain barrier after seizures. These findings point to a profound role of seizure-induced neuronal COX-2 expression in neuropathologies that accompany epileptogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22016518      PMCID: PMC4126152          DOI: 10.1523/JNEUROSCI.3922-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  85 in total

1.  An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia.

Authors:  N Laflamme; S Lacroix; S Rivest
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus.

Authors:  Kristen A Slanina; Paul Schweitzer
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

3.  Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting.

Authors:  L E Mello; E A Cavalheiro; A M Tan; W R Kupfer; J K Pretorius; T L Babb; D M Finch
Journal:  Epilepsia       Date:  1993 Nov-Dec       Impact factor: 5.864

4.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

5.  Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.

Authors:  Dairong Wang; Vickas V Patel; Emanuela Ricciotti; Rong Zhou; Mark D Levin; Ehre Gao; Zhou Yu; Victor A Ferrari; Min Min Lu; Junwang Xu; Hualei Zhang; Yiqun Hui; Yan Cheng; Nataliya Petrenko; Ying Yu; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

6.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

7.  GABA(A) receptor function in epileptic human dentate granule cells: comparison to epileptic and control rat.

Authors:  M D Shumate; D D Lin; J W Gibbs; K L Holloway; D A Coulter
Journal:  Epilepsy Res       Date:  1998-09       Impact factor: 3.045

8.  Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist.

Authors:  V L Marcheselli; N G Bazan
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

9.  New roles for interleukin-1 Beta in the mechanisms of epilepsy.

Authors:  Annamaria Vezzani; Tallie Z Baram
Journal:  Epilepsy Curr       Date:  2007 Mar-Apr       Impact factor: 7.500

10.  Chronic CXCL10 alters neuronal properties in rat hippocampal culture.

Authors:  Jungsook Cho; Thomas E Nelson; Hilda Bajova; Donna L Gruol
Journal:  J Neuroimmunol       Date:  2009-01-22       Impact factor: 3.478

View more
  76 in total

1.  Mechanisms of Seizure-Induced Inflammation of the Brain: Many Possible Roles for Neuronal COX-2.

Authors:  F Edward Dudek
Journal:  Epilepsy Curr       Date:  2012-05       Impact factor: 7.500

Review 2.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

Review 3.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

Review 4.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

5.  Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity.

Authors:  Shekher Mohan; Shuh Narumiya; Sylvain Doré
Journal:  Neurotoxicology       Date:  2014-11-13       Impact factor: 4.294

Review 6.  A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.

Authors:  Asheebo Rojas; Thota Ganesh; Wenyi Wang; Jennifer Wang; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2019-02-25       Impact factor: 5.996

Review 7.  Resolving the Micro-Macro Disconnect to Address Core Features of Seizure Networks.

Authors:  Jordan S Farrell; Quynh-Anh Nguyen; Ivan Soltesz
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

8.  Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.

Authors:  Jianxiong Jiang; Ying Yu; Erika Reime Kinjo; Yifeng Du; Hoang Phuong Nguyen; Ray Dingledine
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

9.  Development of second generation EP2 antagonists with high selectivity.

Authors:  Thota Ganesh; Jianxiong Jiang; Ray Dingledine
Journal:  Eur J Med Chem       Date:  2014-06-03       Impact factor: 6.514

Review 10.  Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches.

Authors:  Nicola Marchi; Tiziana Granata; Chaitali Ghosh; Damir Janigro
Journal:  Epilepsia       Date:  2012-08-20       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.